{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": 3.2857146, "regularMarketPrice": 0.3615, "exchange": "NMS", "shortName": "Finch Therapeutics Group, Inc.", "longName": "Finch Therapeutics Group, Inc.", "messageBoardId": "finmb_320858778", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "bookValue": 1.992, "fiftyDayAverage": 0.3928, "fiftyDayAverageChange": -0.03130001, "fiftyDayAverageChangePercent": -0.07968434, "twoHundredDayAverage": 1.067405, "twoHundredDayAverageChange": -0.70590496, "twoHundredDayAverageChangePercent": -0.66132814, "marketCap": 19224642, "forwardPE": 1.2910714, "priceToBook": 0.18147591, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-03-19", "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.29, "epsForward": 0.28, "epsCurrentYear": -0.35, "priceEpsCurrentYear": -1.0328572, "sharesOutstanding": 48144900, "firstTradeDateMilliseconds": 1616160600000, "priceHint": 4, "regularMarketChange": 0.011500001, "regularMarketTime": 1684180701, "regularMarketDayHigh": 0.3868, "regularMarketDayRange": "0.35 - 0.3868", "regularMarketDayLow": 0.35, "regularMarketVolume": 42793, "regularMarketPreviousClose": 0.35, "bid": 0.0, "ask": 0.0, "bidSize": 11, "askSize": 8, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 0.35, "averageDailyVolume3Month": 285561, "averageDailyVolume10Day": 114060, "fiftyTwoWeekLowChange": 0.061499983, "fiftyTwoWeekLowChangePercent": 0.20499994, "fiftyTwoWeekRange": "0.3 - 3.0", "fiftyTwoWeekHighChange": -2.6385, "fiftyTwoWeekHighChangePercent": -0.8795, "fiftyTwoWeekLow": 0.3, "fiftyTwoWeekHigh": 3.0, "marketState": "PRE", "displayName": "Finch Therapeutics", "symbol": "FNCH"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "200 Inner Belt Road", "address2": "Suite 400", "city": "Somerville", "state": "MA", "zip": "02143", "country": "United States", "phone": "617 229 6499", "website": "https://www.finchtherapeutics.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524, FIN-525, and other microbiome product candidates for inflammatory bowel disease. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mark Burnham Smith Ph.D.", "age": 35, "title": "CEO & Director", "yearBorn": 1987, "fiscalYear": 2022, "totalPay": {"raw": 536745, "fmt": "536.75k", "longFmt": "536,745"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Marc B. Blaustein C.F.A., CFA, MPP", "age": 59, "title": "COO and Principal Financial & Accounting Officer", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 469283, "fmt": "469.28k", "longFmt": "469,283"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Matt  Nelson M.B.A.", "title": "VP of Fin.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. James S. Sigler", "age": 61, "title": "Exec. VP of CMC", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}